BioMarin Pharmaceutical shares owned by UBS Group
Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in BioMarin Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including BioMarin Pharmaceutical held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioMarin Pharmaceutical by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $443M | 5.1M | 87.34 |
| 2023-12-31 | $8.9M | 93k | 96.41 |
| 2023-09-30 | $22M | 245k | 88.47 |
| 2023-06-30 | $26M | 297k | 86.69 |
| 2023-03-31 | $19M | 196k | 97.25 |
| 2022-12-31 | $69M | 667k | 103.50 |
| 2022-09-30 | $84M | 1.2M | 71.43 |
| 2022-06-30 | $221M | 2.7M | 82.05 |
| 2022-03-31 | $229M | 2.9M | 80.00 |
| 2021-12-31 | $16M | 184k | 88.35 |
| 2021-09-30 | $25M | 323k | 77.29 |
| 2021-06-30 | $21M | 255k | 83.45 |
| 2021-03-31 | $17M | 228k | 75.51 |
| 2020-12-31 | $12M | 140k | 87.70 |
| 2020-09-30 | $7.2M | 95k | 76.08 |
| 2020-06-30 | $19M | 155k | 123.34 |
| 2020-03-31 | $15M | 177k | 84.50 |
| 2019-12-31 | $19M | 226k | 84.53 |
| 2019-09-30 | $27M | 398k | 67.40 |
| 2019-06-30 | $18M | 204k | 85.65 |
| 2019-03-31 | $15M | 172k | 88.00 |
| 2018-12-31 | $14M | 159k | 85.14 |
| 2018-09-30 | $17M | 171k | 97.00 |
| 2018-06-30 | $11M | 116k | 93.98 |
| 2018-03-31 | $20M | 245k | 80.00 |
| 2017-12-31 | $17M | 195k | 89.22 |
| 2017-09-30 | $17M | 180k | 93.07 |
| 2017-06-30 | $16M | 180k | 90.82 |
| 2017-03-31 | $14M | 160k | 87.78 |
| 2016-12-31 | $19M | 233k | 82.84 |
| 2016-09-30 | $38M | 407k | 92.52 |
| 2016-06-30 | $13M | 173k | 76.67 |
| 2016-03-31 | $13M | 162k | 82.50 |
| 2015-12-31 | $16M | 157k | 104.76 |
| 2015-09-30 | $22M | 206k | 105.32 |
| 2015-03-31 | $35M | 290k | 120.00 |